Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-01-10 @ 6:15 PM
Study NCT ID:
NCT04675151
Status:
COMPLETED
Last Update Posted:
2025-10-10
First Post:
2020-12-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia
Sponsor:
Ocuphire Pharma, Inc.
Organization:
Study Overview
Official Title:
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) With Pilocarpine Eye Drops in Subjects With Presbyopia
Status:
COMPLETED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objectives of this study are:
To evaluate the efficacy of Nyxol + Pilocarpine to improve DCNVA in subjects with presbyopia
To evaluate the efficacy of Nyxol + Pilocarpine to improve DCNVA in subjects with presbyopia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: